fda - Search News

FDA Approves 1st Non-Opioid Pain Drug in 20 Years

USA TODAY on MSN · 2h

FDA approves new pain medication as an alternative to opioids: What to know about Journavx

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

Newsweek on MSN · 4h

What is Non-Opioid Pain Medication? Journavx Approved by FDA

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

U.S. News & World Report · 1h

FDA Approves First New Non-Opioid Pain Pill in Decades

FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

FDA upgrades recall of Lay's potato chips

Newsweek on MSN · 2d

Chocolate Recall Update As FDA Sets Highest Risk Level for 9 States

A recall which was issued across nine states has now been given the highest risk classification by the federal agency.

USA Today · 1d

Lay's potato chips recall upgraded to FDA's most serious level. Is Ohio affected?

The FDA elevated Lay's Classic Potato Chips to the highest risk level. Here what to know, and whether the recall impacts Ohio.

Hosted on MSN · 23h

Lay's potato chips recalled over life-threatening risk as FDA issues warning

Lay recall on Lay's Classic Potato Chips across Oregon and Washington was updated to a Class 1 recall by the FDA on Thursday.

Ozempic receives FDA nod for treating chronic kidney disease

CNN on MSN · 2d

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,

Hosted on MSN · 1d

Ozempic receives FDA nod for treating chronic kidney disease; experts explain how diabetes drug reduces CKD risk

The US Food and Drug Administration (FDA) approval is based on the clinical trials that showed how Ozempic, the diabetes drug, showed a reduced risk of kidney failure. Experts explain how the drug helps.

HealthDay on MSN · 1d

FDA Approves Ozempic to Protect Kidneys in Patients With Type 2 Diabetes

A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans at risk for kidney failure. The U.S. Food and Drug Administration (FDA) has officially approved Ozempic to help reduce the risk of serious kidney complications in people with type 2 diabetes

1d

FDA Recalls Blood Pressure Drug Over ‘Visible Black’ Contaminants

Medicine may not be an exact science, but precision is crucial for patient care. That’s why the presence of unknown particles ...

19h

US FDA approves Axsome Therapeutics' migraine drug

The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.

4h

FDA Opens Up A New Path To The U.S. Market For This Under 30 Biotech Startup

More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...

How to protect HHS, FDA, NIH, and other health agencies from political interference

When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results